James Baron Wetmore MD
Associate Professor, Internal Medicine, University Kansas School of Medicine
Join to View Full Profile
701 Park AveShapiro 5 NephrologyMinneapolis, MN 55415
Phone+1 612-873-6988
Dr. Wetmore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Nephrology, 2000 - 2005
University of Alabama Medical CenterResidency, Internal Medicine, 1997 - 2000
University of Texas Southwestern Medical SchoolClass of 1997
Certifications & Licensure
CA State Medical License 2000 - Present
MN State Medical License 2013 - 2026
KS State Medical License Active through 2013
AL State Medical License 1998 - 2000
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Association of FGF-23 and Parathyroid Hormone (PTH) in Dialysis Patients Start of enrollment: 2007 Jan 01
Publications & Presentations
PubMed
- Trends in Outcomes Among Patient Initiating Peritoneal Dialysis in the United States, 2009-2018.Christopher Knapp, Shuling Li, Chuanyu Kou, David T Gilbertson, James B Wetmore
American Journal of Kidney Diseases. 2025-07-09 - Health Care Resource Utilization and Costs of Major Adverse Thrombotic Events in Patients with and without ESKD.Nicholas S Roetker, Alejandro Victores, Chuanyu Kou, Lori D Bash, Dena Rosen Ramey
Kidney360. 2025-06-23 - US Renal Data System 2024 Annual Data Report: Epidemiology of Kidney Disease in the United States.Kirsten L Johansen, David T Gilbertson, Shuling Li, Suying Li, Jiannong Liu
American Journal of Kidney Diseases. 2025-06-01
Press Mentions
ESKD Treatment Dropped Sharply During Height of COVID-19 PandemicSeptember 28th, 2021- Highlights from the August 2021 IssueAugust 2nd, 2021
Readmission Rates High for HD Patients After CVD HospitalizationMarch 6th, 2018- Join now to see all
Grant Support
- Factors Associated With Warfarin Use In Dialysis Patients W/ Atrial FibrillationNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
